Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Clonal Architecture Analysis of TET2 Identified Distinct Origins in Myelodysplastic Syndromes

Zhongxun Shi, MD, Bing Li, MD, Tiejun Qin, MD, Zefeng Xu, MD, Lijuan Pan, MD, Shiqiang Qu, MD, Gang Huang, PhD, Zhijian Xiao, MD

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-139329

Published: 2020

Journal Articles

Impact of U2AF1 Mutations on Clinical Characteristics and RNA Splicing in Myelodysplastic Syndromes (MDS)

Bing Li, MD, Jinqin Liu, Tiejun Qin, Zefeng Xu, MD, Gang Huang, PhD, Zhijian Xiao, MD

Blood (2019) 134 (Supplement_1): 2979.

https://doi.org/10.1182/blood-2019-126346

Published: 2019

Journal Articles

Clinical Features and Biological Implications of U2AF1 Mutations in Myelodysplastic Syndromes

Bing Li, Jinqin Liu, Yujiao Jia, MD, Tiejun Qin, Zefeng Xu, MD, Yue Zhang, MD PhD, Gang Huang, PhD, Zhijian Xiao

Blood (2017) 130 (Supplement 1): 586.

https://doi.org/10.1182/blood.V130.Suppl_1.586.586

Published: 2017

Journal Articles

HIF1A Is a Critical Downstream Mediator for Hemophagocytic Lymphohistiocytosis

Blood (2017) 130 (Supplement 1): 3565.

https://doi.org/10.1182/blood.V130.Suppl_1.3565.3565

Published: 2017

Journal Articles

EPO Signaling Triggers Erythrocytosis By Expanding Erythrocytes and Also Subsets of Macrophages

Yoshihiro Hayashi, MD PhD, Jieyu Wang, MD, Zefeng Xu, MD, Xiaomei Yan, MD PhD, Yue Zhang, MD, Theodosia A Kalfa, MD PhD, Zhijian Xiao, MD, Gang Huang, PhD

Blood (2016) 128 (22): 542.

https://doi.org/10.1182/blood.V128.22.542.542

Published: 2016

Journal Articles

Non-Driver Mutations Profile Identified By a 206-Gene NGS Panel in Patients with Primary Myelofibrosis and Post-Polycythaemic/Essential Thromocythaemia Myelofibrosis in a Single Center from China

Bing Li, MD, Lei Zhang, MD, Jie Bai, MD PhD, Zefeng Xu, MD, Tiejun Qin, Yue Zhang, MD, Jinqin Liu, Gang Huang, PhD, Zhijian Xiao, MD

Blood (2016) 128 (22): 1942.

https://doi.org/10.1182/blood.V128.22.1942.1942

Published: 2016

Journal Articles

HIF-1a Pathway, As a Signal Funnel for Genetic, Epigenetic, and Metabolic Aberrations, Is Sufficient and Essential for MDS Development

Blood (2015) 126 (23): 303.

https://doi.org/10.1182/blood.V126.23.303.303

Published: 2015

Journal Articles

Activation of HIF-2a-EPO Axis in Kidney or Liver Is Sufficient to Drive Erythrocytosis in a Novel Inducible HIF-2a Transgenic Mouse Model

Jieyu Wang, MD, Yoshihiro Hayashi, MD PhD, Zefeng Xu, MD, Lingyun Wu, MD PhD, Xiaomei Yan, MD PhD, Theodosia A. Kalfa, MD PhD, Zhijian Xiao, MD, Gang Huang, PhD

Blood (2015) 126 (23): 931.

https://doi.org/10.1182/blood.V126.23.931.931

Published: 2015

Journal Articles

Colony-Forming Unit Cell (CFU-C) Assays in Myelodysplastic Syndrome

Bing Li, MD, Jinqin Liu, Shiqiang Qu, MD, Robert Peter Gale, MD PhD DSc, Ruixian Xing, Tiejun Qin, Yue Zhang, MD, Zefeng Xu, MD, Liwei Fang, Hongli Zhang, MD, Lijuan Pan, Naibo Hu, Gang Huang, PhD, Zhijian Xiao, MD

Blood (2015) 126 (23): 2874.

https://doi.org/10.1182/blood.V126.23.2874.2874

Published: 2015

Journal Articles

A Novel Erythroid Regulator MLF1IP Promotes Proliferation in Mice By Regulating Cell Cycle

Tianjiao Zhang, MD, Xiaotang Ma, PhD, Bing Li, MD, Gang Huang, PhD, Robert Peter Gale, MD PhD DSc, Yue Zhang, MD, Zefeng Xu, MD, Tiejun Qin, Josef T. Prchal, MD, Zhijian Xiao, MD

Blood (2015) 126 (23): 2835.

https://doi.org/10.1182/blood.V126.23.2835.2835

Published: 2015

Journal Articles

Impact of Megakaryocyte Morphology on Prognosis of Persons with Myelodysplastic Syndromes

Gege Feng, MD, Wen Cui, Wenyu Cai, Tiejun Qin, Yue Zhang, MD, Zefeng Xu, MD, Liwei Fang, Hongli Zhang, MD, Lijuan Pan, Naibo Hu, Bing Li, MD, Zhijian Xiao, MD

Blood (2015) 126 (23): 2876.

https://doi.org/10.1182/blood.V126.23.2876.2876

Published: 2015

Journal Articles

Impact of Disease Duration upon Symptom Burden Amongst Patients with Myeloproliferative Neoplasms (MPNs)

Robyn M. Scherber, MD MPH, Holly Geyer, MD, Claire N. Harrison, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, Jean-Jacques Kiladjian, MD PhD, Stefanie Slot, Zhijian Xiao, DO, Sonja Zweegman, MD PhD, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernandez-Maraver, PhD, Konstanze Döhner, MD, Deepti Radia, Pablo J. Muxi, MD, Carlos Besses, Francisco Cervantes, MD PhD, Peter L. Johansson, MD PhD, Bjorn Andreasson, MDPhD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Karin Bonatz, Andreas Reiter, MD, Francoise Boyer, MD, Gabriel Etienne, MD PhD, Jean-Christophe Ianotto, Dana Ranta, Jean Roy, MD, Jean-Yves Cahn, Norman I Maldonado, MD, Giovanni Barosi, MD, Maria Ferrari, Robert Peter Gale, MD PhD DSc, Gunnar Birgegard, MD PhD, Zefeng Xu, MD, Yu Zhang, B.S., Xiujuan Sun, MD, Junqing Xu, Peihong Zhang, Peter A. te Boekhorst, Suzan Commandeur, Harry C. Schouten, MD PhD, Heike L Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Thomas Lehmann, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Jan Samuelsson, MD PhD, Ruben A. Mesa, MD

Blood (2015) 126 (23): 4073.

https://doi.org/10.1182/blood.V126.23.4073.4073

Published: 2015

Journal Articles

Symptom Burden Profile in Myelofibrosis Patients with Thrombocytopenia: Lessons and Unmet Needs

Holly Geyer, MD, Robyn M Scherber, MD MPH, Heidi Kosiorek, Amylou C. Dueck, PhD, Jean-Jacques Kiladjian, MD PhD, Zhijian Xiao, MD, Stefanie Slot, Sonja Zweegman, MD PhD, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernandez-Maraver, PhD, Konstanze Dohner, MD, Claire N. Harrison, Deepti Radia, Pablo J. Muxi, MD, Carlos Besses, Francisco Cervantes, Peter L. Johansson, MD PhD, Bjorn Andreasson, MDPhD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Karin Bonatz, Andreas Reiter, MD, Francoise Boyer, MD, Gabriel Etienne, MD PhD, Jean-Christophe Ianotto, MD, Dana Ranta, Lydia Roy, MD, Jean-Yves Cahn, Norman I Maldonado, MD, Giovanni Barosi, Maria Ferrari, Robert Peter Gale, MD PhD DSc, Gunnar Birgegard, MD PhD, Zefeng Xu, MD, Yue Zhang, MD, Xiujuan Sun, MD, Junqing Xu, Peihong Zhang, Peter te Boekhorst, Suzan Commandeur, Harry C. Schouten, MD PhD, Heike L Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Thomas Lehmann, Alessandro M. Vannucchi, Francesco Passamonti, MD, Jan Samuelsson, MD PhD, Ruben A. Mesa, MD

Blood (2015) 126 (23): 4080.

https://doi.org/10.1182/blood.V126.23.4080.4080

Published: 2015

Journal Articles

Unmet Needs for Symptom Control in Essential Thrombocythemia with Front Line Therapy

Holly Geyer, MD, Robyn M. Scherber, MD MPH, Heidi Kosiorek, M.S., Amylou C. Dueck, PhD, Jean-Jacques Kiladjian, MD PhD, Stefanie Slot, Zhijian Xiao, DO, Sonja Zweegman, MD PhD, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernandez-Maraver, PhD, Konstanze Döhner, MD, Claire N. Harrison, Deepti Radia, Pablo J. Muxi, MD, Carlos Besses, Francisco Cervantes, Peter L. Johansson, MD PhD, Bjorn Andreasson, MDPhD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Karin Bonatz, Andreas Reiter, MD, Francoise Boyer, MD, Gabriel Etienne, MD PhD, Jean-Christophe Ianotto, MD, Dana Ranta, Lydia Roy, MD, Jean-Yves Cahn, Norman I Maldonado, MD, Giovanni Barosi, MD, Maria Ferrari, Robert Peter Gale, MD PhD DSc, Gunnar Birgegard, MD PhD, Zefeng Xu, MD, Yu Zhang, B.S., Xiujuan Sun, MD, Junqing Xu, Peihong Zhang, Peter A. te Boekhorst, Suzan Commandeur, Harry C. Schouten, MD PhD, Heike L Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Thomas Lehmann, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Jan Samuelsson, MD PhD, Ruben A. Mesa, MD

Blood (2015) 126 (23): 5175.

https://doi.org/10.1182/blood.V126.23.5175.5175

Published: 2015

Journal Articles

Prognostic Impact of Splenomegaly on Survival of Chinese with Primary Myelofibrosis

Jingya Wang, Junqing Xu, Robert Peter Gale, MD PhD DSc, FACP, Zefeng Xu, MD, Bing Li, Tiejun Qin, Yue Zhang, Liwei Fang, Hongli Zhang, Lijuan Pan, Shiqiang Qu, Peihong Zhang, Zhijian Xiao, MD

Blood (2014) 124 (21): 3210.

https://doi.org/10.1182/blood.V124.21.3210.3210

Published: 2014

Journal Articles

Novel Myelodysplastic Syndromes-like Mouse Models By Cooperating Genetic/Epigenetic Mutations Reveal the Critical Role of HIF-1α for Disease Development

Yoshihiro Hayashi, MD PhD, Yue Zhang, MD, Xiaomei Yan, MD PhD, Goro Sashida, MD PhD, Zefeng Xu, MD, Yunzhu Dong, Hironori Harada, MD PhD, Zhijian Xiao, MD, Gang Huang, PhD

Blood (2014) 124 (21): 362.

https://doi.org/10.1182/blood.V124.21.362.362

Published: 2014

Journal Articles

Molecular Aberrations of Chronic Neutrophilic Leukemia: The CSF3R and SETBP1 Mutations

Yajuan Cui, Master, Bing Li, Robert Peter Gale, MD PhD DSc, FACP, Qian Jiang, Zefeng Xu, MD, Tiejun Qin, Peihong Zhang, Yue Zhang, Zhijian Xiao, MD

Blood (2014) 124 (21): 5578.

https://doi.org/10.1182/blood.V124.21.5578.5578

Published: 2014

Journal Articles

Symptom Severity and Clinical Variables of Polycythemia Vera Patients with Splenomegaly, Phlebotomy Requirements and/or Hydroxyurea Use: a Retrospective Evaluation of 1334 Patients

Holly Lynn Geyer, MD, Robyn M Scherber, MD MPH, Amylou Constance Dueck, PhD, Jean-Jacques Kiladjian, MD PhD, Zhijian Xiao, MD, Stephanie Slot, BSc, Sonja Zweegman, MDPhD, Ana Kerguelen Fuentes, Dolores Hernández-Maraver, MD PhD, Konstanze Dohner, MD, Claire N. Harrison, DM, FRCP, FRCPath, Deepti H Radia, MDFRCPath MSc MDEd, Pablo J. Muxi, MD, Federico Sackman, Carlos Besses, Francisco Cervantes, MD PhD, Peter L. Johansson, MD PhD, Bjorn Andreasson, MD, Alessandro Rambaldi, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Jan Samuelsson, MD PhD, Gunnar Birgegard, Karin Bonatz, MD, Andreas Reiter, MD, Françoise Boyer, MD, Gabriel Etienne, MD PhD, Jean-Christophe Ianotto, MD, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, Norman I Maldonado, MD, Giovanni Barosi, MD, Maria Ferrari, MD, Keith Cannon, MD, Peter te Boekhorst, MD PhD, Harry C Schouten, MDPhD, Heike L. Pahl, PhD, Martin Griesshammer, Frank Stegelmann, MD, Thomas Lehmann, MD, Zefeng Xu, MD, Yue Zhang, Xiujuan Sun, Junqing Xu, Peihong Zhang, Ruben Mesa, MD

Blood (2014) 124 (21): 1848.

https://doi.org/10.1182/blood.V124.21.1848.1848

Published: 2014

NARROW

Clonal Architecture Analysis of TET2 Identified Distinct Origins in Myelodysplastic Syndromes

Impact of U2AF1 Mutations on Clinical Characteristics and RNA Splicing in Myelodysplastic Syndromes (MDS)

Clinical Features and Biological Implications of U2AF1 Mutations in Myelodysplastic Syndromes

HIF1A Is a Critical Downstream Mediator for Hemophagocytic Lymphohistiocytosis

EPO Signaling Triggers Erythrocytosis By Expanding Erythrocytes and Also Subsets of Macrophages

Non-Driver Mutations Profile Identified By a 206-Gene NGS Panel in Patients with Primary Myelofibrosis and Post-Polycythaemic/Essential Thromocythaemia Myelofibrosis in a Single Center from China

HIF-1a Pathway, As a Signal Funnel for Genetic, Epigenetic, and Metabolic Aberrations, Is Sufficient and Essential for MDS Development

Activation of HIF-2a-EPO Axis in Kidney or Liver Is Sufficient to Drive Erythrocytosis in a Novel Inducible HIF-2a Transgenic Mouse Model

Colony-Forming Unit Cell (CFU-C) Assays in Myelodysplastic Syndrome

A Novel Erythroid Regulator MLF1IP Promotes Proliferation in Mice By Regulating Cell Cycle

Impact of Megakaryocyte Morphology on Prognosis of Persons with Myelodysplastic Syndromes

Impact of Disease Duration upon Symptom Burden Amongst Patients with Myeloproliferative Neoplasms (MPNs)

Symptom Burden Profile in Myelofibrosis Patients with Thrombocytopenia: Lessons and Unmet Needs

Unmet Needs for Symptom Control in Essential Thrombocythemia with Front Line Therapy

Prognostic Impact of Splenomegaly on Survival of Chinese with Primary Myelofibrosis

Novel Myelodysplastic Syndromes-like Mouse Models By Cooperating Genetic/Epigenetic Mutations Reveal the Critical Role of HIF-1α for Disease Development

Molecular Aberrations of Chronic Neutrophilic Leukemia: The CSF3R and SETBP1 Mutations

Symptom Severity and Clinical Variables of Polycythemia Vera Patients with Splenomegaly, Phlebotomy Requirements and/or Hydroxyurea Use: a Retrospective Evaluation of 1334 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only